Dropping Ocrelizumab Could Be Good For Biogen Idec's Cash Flow
The motion-picture-industry themed ocrelizumab RA program won't be taking home any awards with the FILM study on clinical hold and the SCRIPT trial halted after deaths from infection.
The motion-picture-industry themed ocrelizumab RA program won't be taking home any awards with the FILM study on clinical hold and the SCRIPT trial halted after deaths from infection.